Endocrine And Metabolic Diseases Flashcards
What is type 1 diabetes?
An autoimmune disease in which the immune system mediates the destruction of beta-cells.
Which HLA is associated with type 1 DM?
HLA-DQ
HLA-DR2 and DR4
What is the criteria to diagnose type 2 DM?
- Random: >200 (11.1) and patient is symptomatic
- Fasting: >126 (7) on 2 occasions
- 2 -hr postprandial: >200 (11.1) on 2 occasions
- HbA1c: >6.5
What is the criteria to diagnose pre-diabetes or Impaired Glucose Tolerance?
- Fasting BG: 110-126 (5.6-6.9)
- 2-hr postprandial: 140-200 (7.7-11.1)
- HbA1c: 5.7-6.4
What is the criteria for screening DM?
- Started from age of 35 and older, if results are normal repeat within 3 years or earlier depending on risk factors and lab result levels
- Started earlier than 35 year old if patient is overweight or obese with an additional risk factor for T2DM
- Pre-diabetes should be repeated yearly
- Women with gestational diabetes should repeat every 3 years
- HIV infection
What are the general principles of outpatient management and monitoring of all diabetic patients?
- Monitor HbA1c every 3-4 months, not recommended if patient has hemoglobinopathies
- Monitor daily glycemic levels especially if on insulin therapy: before meals, 90-120 minutes after meal and at bedtime
- Screen for microalbuminurea at least once per year, if positive give ACE inhibitor or ARB
- Check BUN, creatinine, urine albumin:creatinine ratio once per year
- Eye screening once per year
- Check the feet at every visit
- Check cholesterol level once per year, give statins if LDL is >100
- Check BP at every visit
- Daily aspirin
- Vaccine
What are the goal levels of microalbumin, BP and lipids?
Microalbumin: < 30 mg/g
BP: <140/90 mmHg
LDL: <70
HDL: >40 in males, >50 in females
Triglycerides: <150
What is the recommended pharmacological treatment for diabetic with high ASCVD risk or high risk individual?
SGLT2 (empagliflozin) or GLP-1 (liraglutide)
What is the recommended pharmacological treatment for diabetic with heart failure?
SGLT-2 (empagliflozin)
What is the recommended pharmacological treatment for patient with CKD?
SGLT-2 (empagliflozin), but if not tolerated or contraindicated GLP-1 can be used instead
What is preprandial and postprandial glycemic target?
Preprandial: <130 (7.2)
Postprandial: <180 (10)
What are the indications for insulin therapy in T2DM?
- If patient’s glycemic targets are not met despite sufficient anti-diabetic treatment
- If patient has contraindications for non-insulin anti-diabetic drugs
- Pregestational and gestational diabetes
- Hyperglycemia crisis
- Newly diagnosed patients with:
- Initial glucose >300 mg/dL or HbA1c >10%
- Symptoms of hyperglycemia
- Signs of a continued catabolic state, e.g. weight loss
What is the amount of basal insulin given in T2DM?
0.2-0.3 units/kg
What is the amount of insulin required in T1DM to achieve glycemic control?
0.5-1 unit/kg per day, divided into 50% basal and 50% prandial insulin
What is the most common cause of death in diabetic patients?
CAD
What are the macrovascular complications of DM?
- Coronary artery disease
- Peripheral vascular disease
- Cerebrovascular disease
What are the microvascular complications of DM?
- Diabetic nephropathy
- Diabetic retinopathy
- Diabetic neuropathy
- Diabetic foot
- Increased susceptibility to infection
What are the key features of DKA?
- Hyperglycemia (>450 mg/dL and <850 mg/dL)
- Positive serum or urine ketones
- Metabolic acidosis (pH <7.3 and HCO3 <18 mEq/L)
How DKA managed?
- Insulin priming dose of 0.1 units/kg of regular insulin (IV) followed by infusion of 0.1 units/kg/hr. BUT withhold insulin if potassium is <3.3 mEq/L, give 20-30 mEq/hr of potassium and once it has reached 3.3-5.2 mEq/L then give insulin
- Fluid replacement of 1L/hr 0.9% saline infusion for the first 2 hours and then 0.5L/hr. Add 5% glucose once blood glucose reaches 200 mg/dL to prevent hypoglycemia.
How is Hyperosmolar Hyperglycemic Nonketotic Syndrome diagnosed?
- Hyperglycemia >900 mg/dL
- Hyperosmolarity >320 mOsm/L
- No acidosis
How is HHNS managed?
- Fluid replacement: 1L in the first hour and another liter in the next 2 hours
- Insulin: check potassium levels before initiating insulin, initial bolus of 0.1 units/kg as IV bolus and then continuous low-dose infusion 0.1 units/kg/hr
What is the most common cause of hyperprolactinemia?
Prolactinoma
What are the clinical features of hyperprolactinemia in men?
- Hypogonadism, decreased libido, infertility, impotence
- Galactorrhea or gynecomastia
- Parasellar signs and symptoms
What are the clinical features of hyperprolactinemia in women?
Premenopausal:
- Menstrual irregularities, oligomenorrhea or amenorrhea, anovulation and infertility, decreased libido, dyspareunia, vaginal dryness, risk of osteoporosis, galactorrhea
Postmenopausal:
- Parasellar signs and symptoms